The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Obliterative bronchiolitis (a pattern consistent with) (see also IVn, XVx)
Publications
Bronchiolar disease associated with gold compounds administration in a patient with rheumatoid arthritis.
Modern rheumatology 2005;15;148-52 — 2005 — 148-52
Gold-induced pulmonary disease: clinical features, outcome, and differentiation from rheumatoid lung disease.
American journal of respiratory and critical care medicine 1997 Mar;155;1011-20 — 1997 Mar — 1011-20
Constrictive bronchiolitis obliterans following gold therapy for psoriatic arthritis.
The European respiratory journal 1995 Dec;8;2191-3 — 1995 Dec — 2191-3